BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mcquaid DC, Panse G, Wang W, Pinkus GS, Katz SG, Xu ML. Global Assessment of IRF8 as a Novel Cancer Biomarker. Human Pathology 2022. [DOI: 10.1016/j.humpath.2022.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu ML, Katz SG. Response to Letter to the Editor: IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias but does not Discriminate Between Monoblasts and Plasmacytoid Dendritic Cells. Am J Surg Pathol 2022. [PMID: 36040049 DOI: 10.1097/PAS.0000000000001961] [Reference Citation Analysis]